Clinical Trial Update: APRICOT-3: Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis -3 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial APRICOT-3 evaluated antithrombotics to prevent reocclusion after coronary thrombolysis in myocardial infarction. The study is completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Heartcenter, University Medical Center St. Radboud | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED | Results posted: 2012-04-19